2015 Next Generation Dx Summit

Short Courses


9:00 am - 12:00 pm

SC1: Use of FFPE/Fixed Tissues for Clinical Research

P. Mickey Williams, Ph.D., Director, Molecular Characterization & Clinical Assay Development Laboratory (MoCha), Frederick National Laboratory for Cancer Research

Jason Lih, Ph.D., Principal Scientist, Molecular Characterization Group, Leidos Biomedical Research, Inc./Frederick National Laboratory for Cancer Research

Biswajit Das, Ph.D., Senior Scientist, MoCha, Frederick National Laboratory for Cancer Research Leidos Biomedical Research, Inc., National Cancer Institute (NCI)

Christopher R. Kinsinger, Ph.D., Program Manager, Office of Cancer Clinical Proteomics Research, NCI

SC2: Method Validation According to CLSI Guidelines

Shuguang Huang, Ph.D., Associate Vice President, Biostatistics, Helomics

SC3: Practical Considerations for NGS Data Analysis and Interpretation

Robert D. Daber, Ph.D., Director, Research and Development and Sequencing Operations,
Bio-Reference Laboratories

Matthew Lebo, Ph.D., FACMG, Director, Bioinformatics, Partners Personalized Medicine; Instructor, Pathology, Brigham and Women’s and Massachusetts General Hospitals

SC4: Biomarkers for Cancer Immunotherapy

Janis Taube, M.D., MSc, Director, Dermatopathology; Assistant Professor, Dermatology and Pathology, Johns Hopkins

2:00 - 5:00 pm

SC5: Microfluidics for Point-of-Care

Holger Becker, Ph.D., Founder & CSO, microfluidic ChipShop GmbHx

SC6: Establishing the Value of Diagnostic Tests

Lawrence J. Worden, Vice President and Senior Partner, Market Diagnostics International

SC7: NGS as a Diagnostics Platform

Jamie L. Platt, Ph.D., Vice President, Genomic Solutions, Molecular Pathology Laboratory Network, Inc.

Jennifer Morrissette, Ph.D., Scientific Director, Clinical Cytogenetics Laboratory, Clinical Director, Center for Personalized Diagnostics (CPD), University of Pennsylvania School of Medicine

SC8: Detection and Characterization of Circulating Biomarkers

Sonya Parpart-Li, Ph.D., Associate Scientist, Personal Genome Diagnostics

5:30 - 8:30 pm Dinner Short Course:

SC9: Regulatory Compliance in Molecular Diagnostics

Melina Cimler, Ph.D., Senior Vice President, Quality & Regulatory, Adaptive Biotechnologies

William Pignato, Regulatory Affairs Consultant, W.J. Pignato & Associates, LLC


Dinner Short Courses 6:30 - 8:30 pm

SC10: Use of CLIA-Waived POC and Rapid Diagnostic Tests in Community Pharmacies

Michael E. Klepser, Pharm.D., FCCP, Professor, Pharmacy Practice, Ferris State University College of Pharmacy

Donald G. Klepser, Ph.D., MBA, Assistant Professor, Pharmacy Practice, University of Nebraska Medical Center College of Pharmacy

Allison Dering-Anderson, Pharm.D., RP, Clinical Assistant Professor, Pharmacy Practice, University of Nebraska Medical Center College of Pharmacy

SC11: NGS for Infectious Disease Diagnostics

Samia Naccache, Ph.D., Associate Specialist, Laboratory Medicine, UCSF

Erik Samayoa, Clinical Lab Scientist, UCSF Viral Diagnostics and Discovery Center

SC12: Regulatory and Reimbursement Considerations with NGS and Other Multiplex Assays

Živana Težak, Ph.D., Associate Director, Science and Technology, Personalized Medicine, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD), Center for Devices and Radiological Health (CDRH), FDA

Girish Putcha, M.D., Ph.D., Director, Laboratory Science, Palmetto GBA (MolDX)


*Separate registration required

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 

2015 Brochure


Premier Sponsor

ThermoFisher Scientific logo 

Related Products